FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:1429 November 23, 1995 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Calcium-channel blockers are associated with rashes, including light-induced and lichenoid eruptions. An association with lupus erythematosus has been reported, although the patient and the nature of the lesion were not described.¹

In four patients (two men and two women, 76 to 81 years old) subacute lupus erythematosus–like eruptions developed during treatment with diltiazem. All four had light-induced eruptions and positive tests for antinuclear antibodies, with antibodies to Ro in three patients and to La in two. None of the patients had marked extracutaneous disease. Diltiazem had been used for an average of 2.5 years before the development . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Saladi, R. N., Cohen, S. R., Phelps, R. G., Persaud, A. N., Rudikoff, D. (2006). Diltiazem induces severe photodistributed hyperpigmentation: case series, histoimmunopathology, management, and review of the literature.. Arch Dermatol 142: 206-210 [Abstract] [Full Text]  
• Srivastava, M., Rencic, A., Diglio, G., Santana, H., Bonitz, P., Watson, R., Ha, E., Anhalt, G. J., Provost, T. T., Nousari, C. H. (2003). Drug-Induced, Ro/SSA-Positive Cutaneous Lupus Erythematosus. Arch Dermatol 139: 45-49 [Abstract] [Full Text]  
• Ghate, J. V., Turner, M. L., Rudek, M. A., Figg, W. D., Dahut, W., Dyer, V., Pluda, J. M., Reed, E. (2001). Drug-Induced Lupus Associated With COL-3: Report of 3 Cases. Arch Dermatol 137: 471-474 [Abstract] [Full Text]  
• Olsen, J. H., Sorensen, H. T., Friis, S., McLaughlin, J. K., Steffensen, F. H., Nielsen, G. L., Andersen, M., Fraumeni, J. F. Jr, Olsen, J. (1997). Cancer Risk in Users of Calcium Channel Blockers. Hypertension 29: 1091-1094 [Abstract] [Full Text]